Confirma gets $17.5m for CAD:
This article was originally published in Clinica
Confirma is looking to expand the applications of its CADstream computer-aided-detection technology with the $17.5m it raised in a series C financing. The Bellevue, Washington firm's system for breast MRI has a worldwide installed based of around a thousand units and the company is currently developing the technology for prostate MRI. The investment round was led by Telegraph Hill Partners and included the participation of new investor Fluke Venture Partners and Confirma's existing shareholders.
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Development Partners International, CDC Group and the European Bank for Reconstruction and Development have collaborated to create a “first of its kind, pan-African” generics platform built on the acquisition and combination of Egypt’s Adwia Pharmaceuticals and India’s Celon Laboratories. An initial $250m investment is to be followed by up to $500m in further funding.
Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9BN By 2024 Amid Rising Chronic Disease
The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.